Literature DB >> 19036917

An evidence synthesis approach to estimating Hepatitis C prevalence in England and Wales.

D De Angelis1, M Sweeting, Ae Ades, M Hickman, V Hope, M Ramsay.   

Abstract

In England and Wales, routine monitoring has been consistently showing an increase in mortality and morbidity due to infection with the Hepatitis C Virus (HCV). However, the magnitude of the underlying epidemic is still the subject of debate. In this paper we present estimates of the number of individuals aged 15-59 chronically infected with HCV in 2003, derived from a Bayesian synthesis of information available from multiple sources on the size of the groups at risk for HCV and the risk specific anti-HCV prevalence. Results show that the number of chronic infections is of the order of 142,000 (95% CrI: 90,000, 231,000), with the majority (85%, 95% CrI: 74%, 93%) in injecting drug users and about 80% (95% CrI: 74%, 84%) in the age group 15-44.

Entities:  

Mesh:

Year:  2008        PMID: 19036917     DOI: 10.1177/0962280208094691

Source DB:  PubMed          Journal:  Stat Methods Med Res        ISSN: 0962-2802            Impact factor:   3.021


  34 in total

1.  Calibrating models in economic evaluation: a seven-step approach.

Authors:  Tazio Vanni; Jonathan Karnon; Jason Madan; Richard G White; W John Edmunds; Anna M Foss; Rosa Legood
Journal:  Pharmacoeconomics       Date:  2011-01       Impact factor: 4.981

Review 2.  Mathematical models for the study of HIV spread and control amongst men who have sex with men.

Authors:  Narat Punyacharoensin; William John Edmunds; Daniela De Angelis; Richard Guy White
Journal:  Eur J Epidemiol       Date:  2011-09-20       Impact factor: 8.082

3.  Case-finding for hepatitis C in primary care: a mixed-methods service evaluation.

Authors:  Shivani Datta; Jeremy Horwood; Matthew Hickman; Debbie Sharp
Journal:  Br J Gen Pract       Date:  2014-02       Impact factor: 5.386

4.  Importance and Contribution of Community, Social, and Healthcare Risk Factors for Hepatitis C Infection in Pakistan.

Authors:  Adam Trickey; Margaret T May; Charlotte Davies; Huma Qureshi; Saeed Hamid; Hassan Mahmood; Quaid Saeed; Matthew Hickman; Nancy Glass; Francisco Averhoff; Peter Vickerman
Journal:  Am J Trop Med Hyg       Date:  2017-10-12       Impact factor: 2.345

5.  Is increased hepatitis C virus case-finding combined with current or 8-week to 12-week direct-acting antiviral therapy cost-effective in UK prisons? A prevention benefit analysis.

Authors:  Natasha K Martin; Peter Vickerman; Iain F Brew; Joan Williamson; Alec Miners; William L Irving; Sushma Saksena; Sharon J Hutchinson; Sema Mandal; Eamonn O'Moore; Matthew Hickman
Journal:  Hepatology       Date:  2016-03-22       Impact factor: 17.425

6.  Combination interventions to prevent HCV transmission among people who inject drugs: modeling the impact of antiviral treatment, needle and syringe programs, and opiate substitution therapy.

Authors:  Natasha K Martin; Matthew Hickman; Sharon J Hutchinson; David J Goldberg; Peter Vickerman
Journal:  Clin Infect Dis       Date:  2013-08       Impact factor: 9.079

Review 7.  Hepatitis C virus treatment as prevention in people who inject drugs: testing the evidence.

Authors:  Matthew Hickman; Daniela De Angelis; Peter Vickerman; Sharon Hutchinson; Natasha Kaleta Martin
Journal:  Curr Opin Infect Dis       Date:  2015-12       Impact factor: 4.915

Review 8.  The hepatitis C virus epidemics in key populations (including people who inject drugs, prisoners and MSM): the use of direct-acting antivirals as treatment for prevention.

Authors:  Natasha K Martin; Peter Vickerman; Gregory J Dore; Matthew Hickman
Journal:  Curr Opin HIV AIDS       Date:  2015-09       Impact factor: 4.283

9.  Developing and Piloting a Standardized European Protocol for Hepatitis C Prevalence Surveys in the General Population (2016-2019).

Authors:  Ida Sperle; Stine Nielsen; Viviane Bremer; Martyna Gassowski; Henrikki Brummer-Korvenkontio; Roberto Bruni; Anna Rita Ciccaglione; Elena Kaneva; Kirsi Liitsola; Zlatina Naneva; Tanya Perchemlieva; Enea Spada; Salla E Toikkanen; Andrew J Amato-Gauci; Erika Duffell; Ruth Zimmermann
Journal:  Front Public Health       Date:  2021-05-28

10.  Hepatitis C prevalence in Denmark -an estimate based on multiple national registers.

Authors:  Peer Brehm Christensen; Gordon Hay; Peter Jepsen; Lars Haukali Omland; Søren Andreas Just; Henrik Bygum Krarup; Nina Weis; Niels Obel; Susan Cowan
Journal:  BMC Infect Dis       Date:  2012-08-06       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.